A detailed history of Nebula Research & Development LLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 39,305 shares of OSUR stock, worth $142,284. This represents 0.02% of its overall portfolio holdings.

Number of Shares
39,305
Previous 44,458 11.59%
Holding current value
$142,284
Previous $189 Million 11.38%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.93 - $4.59 $20,251 - $23,652
-5,153 Reduced 11.59%
39,305 $168 Million
Q2 2024

Aug 14, 2024

BUY
$4.2 - $6.18 $186,723 - $274,750
44,458 New
44,458 $189 Million
Q4 2023

Feb 14, 2024

SELL
$5.13 - $8.35 $1,313 - $2,137
-256 Reduced 1.78%
14,126 $116 Million
Q3 2023

Nov 14, 2023

BUY
$4.4 - $6.91 $63,280 - $99,379
14,382 New
14,382 $85.3 Million

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $263M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.